152 related articles for article (PubMed ID: 32890314)
21. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
22. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J
Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
[TBL] [Abstract][Full Text] [Related]
23. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
Hu B; Li JG; Liang H; Zhou Q; Yu Z; Li L; Luo Y; Liu C; Gan Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):529-31. PubMed ID: 19751560
[TBL] [Abstract][Full Text] [Related]
24. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
[TBL] [Abstract][Full Text] [Related]
25. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.
Marik PE; Khangoora V; Rivera R; Hooper MH; Catravas J
Chest; 2017 Jun; 151(6):1229-1238. PubMed ID: 27940189
[TBL] [Abstract][Full Text] [Related]
26. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.
Gordon AC; Mason AJ; Perkins GD; Stotz M; Terblanche M; Ashby D; Brett SJ
Crit Care Med; 2014 Jun; 42(6):1325-33. PubMed ID: 24557425
[TBL] [Abstract][Full Text] [Related]
27. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
[TBL] [Abstract][Full Text] [Related]
28. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.
Oppert M; Reinicke A; Gräf KJ; Barckow D; Frei U; Eckardt KU
Intensive Care Med; 2000 Dec; 26(12):1747-55. PubMed ID: 11271081
[TBL] [Abstract][Full Text] [Related]
29. Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study.
Bonnin S; Radosevich JJ; Lee YG; Feldman JP; Barletta JF
J Crit Care; 2021 Apr; 62():111-116. PubMed ID: 33338674
[TBL] [Abstract][Full Text] [Related]
30. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R;
Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054
[TBL] [Abstract][Full Text] [Related]
31. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
[TBL] [Abstract][Full Text] [Related]
32. Comparing hydrocortisone and methylprednisolone in patients with septic shock.
Yu TJ; Liu YC; Yu CC; Tseng JC; Hua CC; Wu HP
Adv Ther; 2009 Jul; 26(7):728-35. PubMed ID: 19629409
[TBL] [Abstract][Full Text] [Related]
33. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.
McDonnell E; Collins R; Hernandez M; Brown ART
J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618
[TBL] [Abstract][Full Text] [Related]
34. Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
Coloretti I; Biagioni E; Venturelli S; Munari E; Tosi M; Roat E; Brugioni L; Gelmini R; Venturelli C; Girardis M
J Crit Care; 2020 Oct; 59():37-41. PubMed ID: 32512351
[TBL] [Abstract][Full Text] [Related]
35. Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan.
Fujii T; Udy AA; Deane AM; Luethi N; Bailey M; Eastwood GM; Frei D; French C; Orford N; Shehabi Y; Young PJ; Bellomo R;
Crit Care Resusc; 2019 Jun; 21(2):119-125. PubMed ID: 31142242
[TBL] [Abstract][Full Text] [Related]
36. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
37. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH
J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720
[TBL] [Abstract][Full Text] [Related]
38. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.
Katsenos CS; Antonopoulou AN; Apostolidou EN; Ioakeimidou A; Kalpakou GT; Papanikolaou MN; Pistiki AC; Mpalla MC; Paraschos MD; Patrani MA; Pratikaki ME; Retsas TA; Savva AA; Vassiliagkou SD; Lekkou AA; Dimopoulou I; Routsi C; Mandragos KE;
Crit Care Med; 2014 Jul; 42(7):1651-7. PubMed ID: 24674923
[TBL] [Abstract][Full Text] [Related]
39. Effects of Increasing Hydrocortisone to 300 mg Per Day in the Treatment of Septic Shock: a Pilot Study.
Hyvernat H; Barel R; Gentilhomme A; Césari-Giordani JF; Freche A; Kaidomar M; Goubaux B; Pradier C; Dellamonica J; Bernardin G
Shock; 2016 Nov; 46(5):498-505. PubMed ID: 27405061
[TBL] [Abstract][Full Text] [Related]
40. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]